2016
DOI: 10.1055/s-0036-1588672
|View full text |Cite
|
Sign up to set email alerts
|

Ugi Four-Center Three-Component Reaction as a Direct Approach to Racetams

Abstract: We report the synthesis of racetams, a diverse class of small molecule drugs, by means of the Ugi four-center three-component reaction (U4C-3CR). For the first time, γ-aminobutyric acid is employed as bifunctional input in the Ugi reaction. This protocol is simple, general, and allows one-pot access to a range of drugs and bioactive small molecules.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 8 publications
0
6
0
1
Order By: Relevance
“…This compound was conveniently prepared by Eschenmoser sulfide contraction [29,30], as shown in Scheme 2. The route entailed initial alkylation of the anion of pyrrolidin-2-one (16) with ethyl bromoacetate to afford the known compound ethyl 2-(2-oxopyrrolidin-1-yl)acetate (17) [31][32][33] in 77% yield. Thionation of 17 with Lawesson's reagent in toluene at 80 °C gave the thione 18 as a yellow oil (86%).…”
Section: Resultsmentioning
confidence: 99%
“…This compound was conveniently prepared by Eschenmoser sulfide contraction [29,30], as shown in Scheme 2. The route entailed initial alkylation of the anion of pyrrolidin-2-one (16) with ethyl bromoacetate to afford the known compound ethyl 2-(2-oxopyrrolidin-1-yl)acetate (17) [31][32][33] in 77% yield. Thionation of 17 with Lawesson's reagent in toluene at 80 °C gave the thione 18 as a yellow oil (86%).…”
Section: Resultsmentioning
confidence: 99%
“…There is great potential to synthesize complex drug molecules from deuterated small molecules with modular approaches. Examples of approved drugs which can be made by an MCR route, but are not necessarily produced by an MCR include, atorvastatin, 11 praziquantel, 12 ivosidenib, 13 lidocaine, 14 telaprevir, 14 olanzapine, 15 clopidogrel, 15 lacosamide, 4 carfentanil, 16 nirmatrelvir, 17 amenamevir, 18 or levetiracetam 19 (Figure 3). Olanzapine is a particularly intriguing example on the potential impact of MCR in isotope labeling, since it has been shown to be producible by several convergent MCR routes.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…O levetiracetam é obtido através da utilização de uma reação de Ugi 4-centros-3-componentes (a reação possui os quatro grupos funcionais reativos clássicos, mas o ácido γ-aminobutírico fornece dois desses grupos), formando assim um anel γ-lactâmico. Os dois diastereoisómeros formados são subsequentemente separados para obter o fármaco na forma enantiomericamente pura (Esquema 3) [36]. No caso da lacosamida, uma reação de Ugi de quatro componentes é aplicada, usando uma amina quiral para induzir a formação preferencial de um diastereoisómero, que após desproteção leva à formação da substância ativa na forma enantiomericamente pura (Esquema 3) [37].…”
Section: Um Caso Particular De Rmc -A Reação De Ugiunclassified